Mirati Therapeutics, Inc.·4/A

Nov 12, 6:21 PM ET

REED VICKIE S 4/A

4/A · Mirati Therapeutics, Inc. · Filed Nov 12, 2020

Insider Transaction Report

Form 4/AAmended
Period: 2020-11-02
REED VICKIE S
SVP, Chief Accounting Officer
Transactions
  • Award

    Option Grant (Right to Buy)

    2020-11-02+2,5222,522 total
    Exercise: $216.11Exp: 2030-11-01CommonStock (2,522 underlying)
Footnotes (2)
  • [F1]Quantity reduced by 1 share after corrected calculation of fair value.
  • [F2]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.

Documents

1 file
  • 4
    marketforms-50109.xml

    PRIMARY DOCUMENT